首页> 中文期刊> 《牡丹江医学院学报》 >前哨淋巴结阳性早期乳腺癌其腋窝淋巴结转移状况的研究

前哨淋巴结阳性早期乳腺癌其腋窝淋巴结转移状况的研究

             

摘要

目的:探讨早期乳腺癌前哨淋巴结( sentinel lymphnode ,SLN)阴性患者、1枚阳性SLN患者与2枚以上阳性SLN患者的非前哨淋巴结( non-sentinel lymphnode,NSLN)转移状况。方法:对90例T1-2N0M0乳腺癌患者应用美蓝为示踪剂行前哨淋巴结活检术( sentinel lymphnode biopsy,SLNB),进再行常规腋窝淋巴结清扫术( axillary lymph node dissection,ALND),根据检查结果将患者分成SLN(-)组、SLN(+)=1组及SLN(+)≥2组,并对各组的NSLN阳性率进行比较。结果:32例SLN (-)组检出NSLN阳性1例,阳性率3.1%,39例SLN(+)=1组检出NSLN阳性4例,阳性率为10.3%,19例SLN(+)≥2组检出NSLN阳性9例,阳性率为47.4%,SLNB检查假阴性1例,准确率为96.9%;SLN(+)=1组的NSLN阳性率略高于SLN阴性组,但差异无统计学意义P>0.05;SLN(+)≥2组患者的NSLN阳性率显著高于SLN(-)组及SLN(+)=1组,差异均具有统计学意义P<0.05。结论:研究结果提示1枚SLN阳性患者可仅行SLNB免行ALND,但≥2枚SLN阳性患者则需常规行ALND。%Objective:To explore the early sentinel lymph node in breast cancer ( sentinel, lymphnode, SLN) non sentinel lymph node negative patients, 1 positive in SLN patients with more than 2 pieces of SLN patients with positive nodes ( non-sentinel lymph-node, NSLN) metastasis.Methods:90 T1-2N0M0 patients with breast cancer using methylene blue as tracer for sentinel lymph node biopsy ( sentinel lymphnode biopsy, SLNB ) , and enter the routine axillary lymphadenectomy ( axillary lymph node dissection, ALND) , according to the test results of the patients were divided into SLN ( -) group, =1 group and SLN ( +) SLN ( +) ≥2 groups, and each group of NSLN positive rates were compared.Results:32 cases of SLN (-) group was 1 cases with positive NSLN, the positive rate was 3.1%, 39 cases of SLN (+) =1 was detected in 4 cases of NSLN positive, the positive rate was 10.3%, 19 ca-ses of SLN (+) ≥2 group were NSLN positive in 9 cases, the positive rate was 47.4%, SLNB examination of 1 cases of false nega-tive, the accuracy rate was 96.9%;the positive rate of SLN (+) NSLN in =1 group was higher than that in SLN negative group, but no significant difference between P0.05;SLN ( +) ≥ NSLN positive rate in patients of the 2 groups were significantly higher than that of SLN (-) group and SLN (+) in =1 group, the differences were statistically significant P0.05.Conclusion:The results suggest that the 1 SLN positive patients can only SLNB free ALND, patients with positive but≥2 SLN requires routine ALND.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号